Takashi Kobayashi, Kohei Miura, Hirosuke Ishikawa, Jun Sakata, Kazuyasu Takizawa, Yuki Hirose, Koji Toge, Seiji Saito, Shun Abe, Yusuke Kawachi, Hiroshi Ichikawa, Yoshifumi Shimada, Yoshiaki Takahashi, Toshifumi Wakai, Yoshiaki Kinoshita
OBJECTIVES: De novo malignancy (DNM) is a major cause of death in long-term recipients of liver transplantation (LT). We herein report our experience with DNM after living-donor LT (LDLT). PATIENTS AND METHODS: A total of 111 LDLT procedures were performed in our institute from 1999 to 2022. Among them, 70 adult (>13 years old) LDLT recipients who survived for more than 1 year were included in this study. RESULTS: During a median follow-up of 146 (range, 12-285) months, 7 out of 70 recipients developed 8 DNMs, including lung cancer in 4, post-transplant lymphoproliferative disease in 3, and skin cancer in 1...
March 21, 2024: Transplantation Proceedings